The short form-36 (SF-36) is a widely used questionnaire assessing self-reported HRQOL in eight health domains. The aims of this study were to provide normative data for the SF-36 version 2 (SF-36v2) for all language regions in Switzerland and weighting coefficients to calculate two ...
The SF-36 v2 is a short-form health survey with 36 questions that yields an eight-scale profile (PF, physical functioning; RP, role physical; BP, bodily pain; GH, general health; VT, vitality; SF, social functioning; RE, role emotional; MH, mental health) of functional health and well...
Mean ChQOL and SF-36V2 scores... W Wong,LKC Lam,R Li,... - 《Complementary Therapies in Medicine》 被引量: 22发表: 2011年 Relative effectiveness and adverse effects of cervical manipulation, mobilisation and the activator instrument in patients with sub-acute non-specific neck... p pBack...
BACKGROUND: The purpose of this study was to evaluate the validity of the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) for examining out... EJ Mackenzie,ML Mccarthy,JF Ditunno,... - 《Journal of Trauma & Acute Care Surgery》 被引量: 242发表: 2002年 ...
instrument, which was derived from the Short-Form Health Survey (SF-36). The conceptual equivalence between the original English version and the Simplified Chinese version of SF-6Dv2 has been established in previous studies [24,25,26]. The SF-6Dv2 has six dimensions: physical functioning (PF...
Thus, LPS-mediated acute inflammation may not involve TM4SF5, unlike TM4SF5-dependent chronic inflammation. CCL20 and CXCL10 expression in TM4SF5-positive hepatocytes is enhanced by M1-type MΦ IL-6 Next, we asked how hepatocytes were influenced by MΦs. When hepatocytes were treated with...
Extra Physical Therapy Reduces Patient Length of Stay and Improves Functional Outcomes and Quality of Life in People With Acute or Subacute Conditions: A S... SF-36 Medical Outcomes Study 36-Item Short-Form Health SurveyMedical Outcomes Study 36-Item Short-Form Health SurveySMD standardized mean ...
Received: 12 June 2017; Accepted: 24 July 2017; Published: 28 July 2017 Abstract: Cutaneous malignant melanoma is an aggressive and potentially lethal form of skin cancer, particularly in its advanced and therapy-resistant stages, and the need for novel therapeutics and prognostic tools is acute....